Download full-text PDF |
Source |
---|
Am J Ophthalmol
May 2022
From the Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust (J.C.-K., K.X., T.L.E., R.E.M.), Oxford, United Kingdom; Nuffield Laboratory of Ophthalmology, University of Oxford (J.C.-K., K.X., T.L.E., R.E.M.), Oxford, United Kingdom; and Preceyes BV (T.C.M., M.J.B., G.J.N., M.D.S.), Eindhoven, the Netherlands.
Purpose: To report the results of a first-in-human study using a robotic device to assist subretinal drug delivery in patients undergoing vitreoretinal surgery for macular hemorrhage.
Design: Double-armed, randomized controlled surgical trial (ClinicalTrials.gov identifier: NCT03052881).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!